Comparing Memantine and Escitalopram for Alcohol Dependence with Depression
Author Information
Author(s): Leea H Muhonen, Jari Lahti, David Sinclair, Jouko Lönnqvist, Hannu Alho
Primary Institution: National Public Health Institute, Department of Mental Health and Alcohol Research, Finland
Hypothesis
Can memantine reduce alcohol consumption and craving in patients with alcohol dependence and major depressive disorder more effectively than escitalopram?
Conclusion
Both memantine and escitalopram are effective in treating alcohol dependence co-morbid with major depression, with memantine showing comparable effectiveness to escitalopram.
Supporting Evidence
- Both medications significantly reduced alcohol consumption as measured by the AUDIT scores.
- Patients treated with memantine reported a decrease in alcohol craving similar to those treated with escitalopram.
- Early age at first alcohol intoxication predicted poor treatment outcomes in patients treated with escitalopram.
Takeaway
This study looked at two medicines to help people who drink too much and feel sad. Both medicines helped, but memantine worked just as well as the other one.
Methodology
Eighty alcohol-dependent patients were randomized to receive either memantine or escitalopram for 26 weeks, with weekly visits to monitor alcohol use and craving.
Potential Biases
Potential bias due to the absence of a placebo control and the reliance on self-reported measures.
Limitations
The study lacked a placebo group and had a small sample size, which may limit the generalizability of the results.
Participant Demographics
All participants were Caucasian, aged 26 to 65, with 55% being men.
Statistical Information
P-Value
p<0.0001
Confidence Interval
95% CI = -0.53 to -0.09
Statistical Significance
p<0.0001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website